Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9191 |
High Similarity |
NPD1510 |
Phase 2 |
0.9037 |
High Similarity |
NPD1240 |
Approved |
0.8905 |
High Similarity |
NPD1607 |
Approved |
0.8881 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8857 |
High Similarity |
NPD1549 |
Phase 2 |
0.8786 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8786 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8582 |
High Similarity |
NPD2796 |
Approved |
0.8552 |
High Similarity |
NPD6799 |
Approved |
0.8493 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8472 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8456 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8411 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8369 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8301 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8278 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8224 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8219 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8176 |
Intermediate Similarity |
NPD1511 |
Approved |
0.817 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8133 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8129 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8117 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8117 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8052 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8052 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8012 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7905 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7881 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7877 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7877 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7823 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7785 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7778 |
Intermediate Similarity |
NPD920 |
Approved |
0.7771 |
Intermediate Similarity |
NPD5402 |
Approved |
0.777 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7758 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.775 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD919 |
Approved |
0.773 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD943 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7669 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7664 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7647 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7643 |
Intermediate Similarity |
NPD9717 |
Approved |
0.764 |
Intermediate Similarity |
NPD1247 |
Approved |
0.761 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7605 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7566 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7551 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.753 |
Intermediate Similarity |
NPD7472 |
Approved |
0.753 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7517 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7466 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7386 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7381 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7342 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2797 |
Approved |
0.723 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4288 |
Approved |
0.72 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.72 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1876 |
Approved |
0.716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7123 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7118 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7114 |
Intermediate Similarity |
NPD411 |
Approved |
0.7114 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7113 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7086 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7083 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7079 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7078 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7059 |
Intermediate Similarity |
NPD74 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD9267 |
Approved |
0.6985 |
Remote Similarity |
NPD9264 |
Approved |
0.6985 |
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.6985 |
Remote Similarity |
NPD9263 |
Approved |
0.6974 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6968 |
Remote Similarity |
NPD2353 |
Approved |
0.6968 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6943 |
Remote Similarity |
NPD7003 |
Approved |
0.6933 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6932 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1608 |
Approved |
0.6918 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6913 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD3140 |
Approved |
0.6908 |
Remote Similarity |
NPD3142 |
Approved |
0.6908 |
Remote Similarity |
NPD1613 |
Approved |
0.6903 |
Remote Similarity |
NPD5404 |
Approved |
0.6903 |
Remote Similarity |
NPD5405 |
Approved |
0.6903 |
Remote Similarity |
NPD5406 |
Approved |
0.6903 |
Remote Similarity |
NPD5408 |
Approved |
0.6899 |
Remote Similarity |
NPD6190 |
Approved |
0.6885 |
Remote Similarity |
NPD6776 |
Approved |
0.6885 |
Remote Similarity |
NPD6778 |
Approved |
0.6885 |
Remote Similarity |
NPD6780 |
Approved |
0.6885 |
Remote Similarity |
NPD6777 |
Approved |
0.6885 |
Remote Similarity |
NPD6781 |
Approved |
0.6885 |
Remote Similarity |
NPD6779 |
Approved |
0.6885 |
Remote Similarity |
NPD6782 |
Approved |
0.6879 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD9268 |
Approved |
0.6875 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD940 |
Approved |
0.6866 |
Remote Similarity |
NPD846 |
Approved |
0.6865 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6864 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6859 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6854
|
Remote Similarity |
NPD4287 |
Approved |